Korean J Gastroenterol.  2016 Dec;68(6):334-335. 10.4166/kjg.2016.68.6.334.

The Clinical Importance of Pressurization along the Pyloric Ring Using Manometry and EndoFLIP in Patients with Nausea and Vomiting

• Jung KW

• KMID: 2383466
• DOI: http://doi.org/10.4166/kjg.2016.68.6.334

Abstract

No abstract available.

MeSH Terms

Humans
Manometry*
Nausea*
Vomiting*

Reference

References

1. Talley NJ. Functional nausea and vomiting. Aust Fam Physician. 2007; 36:694–697.

2. Pasricha PJ, Colvin R, Yates K, et al. Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. Clin Gastroenterol Hepatol. 2011; 9:567–576. e1–4.

3. Camilleri M, Brown ML, Malagelada JR. Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology. 1986; 91:94–99.

4. Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology. 1986; 90:1919–1925.

5. Grover M, Farrugia G, Lurken MS, Bernard CE, Faussone-Pellegrini MS, Smyrk TC, et al. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology. 2011; 140:1575–1585.e8.

6. Faussone-Pellegrini MS, Grover M, Pasricha PJ, et al. Ultrastruc-tural differences between diabetic and idiopathic gastroparesis. J Cell Mol Med. 2012; 16:1573–1581.

7. Kwiatek MA, Pandolfino JE, Hirano I, Kahrilas PJ. Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP). Gastrointest Endosc. 2010; 72:272–278.

8. Malik Z, Sankineni A, Parkman HP. Assessing pyloric sphincter pathophysiology using EndoFLIP in patients with gastroparesis. Neurogastroenterol Motil. 2015; 27:524–531.

9. Gourcerol G, Tissier F, Melchior C, et al. Impaired fasting pyloric compliance in gastroparesis and the therapeutic response to pyloric dilatation. Aliment Pharmacol Ther. 2015; 41:360–367.

10. Snape WJ, Lin MS, Agarwal N, Shaw RE. Evaluation of the pylorus with concurrent intraluminal pressure and EndoFLIP in patients with nausea and vomiting. Neurogastroenterol Motil. 2016; 28:758–764.

11. Perretta S, McAnena O, Botha A, et al. Acta from the EndoFLIP® symposium. Surg Innov. 2013; 20:545–552.

12. Gourcerol G, Granier S, Bridoux V, Menard JF, Ducrotté P, Leroi AM. Do endoflip assessments of anal sphincter distensibility provide more information on patients with fecal incontinence than high-resolution anal manometry? Neurogastroenterol Motil. 2016; 28:399–409.

13. Massey BT. EndoFLIP assessment of achalasia therapy: inter-preting the distensibility data is a bit of a stretch. Gastroenterology. 2013; 144:e17–e18.

14. Clarke JO, Snape WJ Jr. Pyloric sphincter therapy: botulinum toxin, stents, and pyloromyotomy. Gastroenterol Clin North Am. 2015; 44:127–136.